Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Consumer Defensives Breadcrumb chevron Food & Drug Retailing Breadcrumb chevron Zhongzhi Pharmaceutical Holdings
Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings News Story

HK$1.32 0.0  1.5%

Last Trade - 8:29am

Sector
Consumer Defensives
RiskRating
Balanced
Size
Small Cap
Style
Contrarian
Market Cap £102.2m
Enterprise Value £90.6m
Revenue £178.4m
Position in Universe 3230th / 6086
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions 3737 Dividends
All News

BRIEF-Zhongzhi Pharmaceutical Says Unit Subscribed For Wealth Management Product Of RMB80 Mln

Zhongzhi Pharmaceutical Holdings News
Tue 7th July, 2020 4:21pm
July 7 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
 3737.HK :
    * UNIT SUBSCRIBED FOR WEALTH MANAGEMENT PRODUCT OF GUANGDONG
HUAXING BANK ZHONGSHAN BRANCH IN AMOUNT OF RMB80 MILLION

Source text for Eikon:  ID:nHKS74R4f4 
Further company coverage:  3737.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhongzhi Pharmaceutical Holdings

See all news
BRIEF-Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB138.5 Mln Vs RMB114.7 Mln
25th Mar News
BRIEF-Zhongzhi Pharmaceutical Says Lai Ying Feng Appointed As A Chief Executive In Place Of Lai Zhi Tian
25th Mar News
BRIEF-Zhongzhi Pharmaceutical Says Lai Ying Sheng Appointed Chief Financial Officer
25th Mar News
BRIEF-Zhongzhi Pharmaceutical Says Unit Entered Yunfu Factory Second Construction Contract
25th Mar News
BRIEF-Zhongzhi Pharmaceutical Says Unit Subscribed For Wealth Management Product Of RMB80 Mln
7th Jul '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.